4 articles tagged
The Swiss medical technology sector faces potential special tariffs from the US, which is investigating imports for national security risks. Switzerland is negotiating to avoid new duties.
Switzerland's medtech industry, already facing economic pressure, now confronts a new threat of U.S. tariffs that could remove long-standing exemptions.
The US has imposed 100 percent tariffs on Swiss pharmaceutical products, sparking concern in Switzerland. Basel, a major pharma hub, is lobbying for its industry as the Swiss government seeks a nation
Talks between the Swiss Federal Council and the pharmaceutical industry concluded without a clear solution to address US tariff policy. Economics Minister Guy Parmelin described the exchange as "const
